Receptive CPE Activities
Truqap ( Capivasertib ): a kinase inhibitor, in combination with Faslodex ( Fulvestrant ) for HR+ve, HER2-ve, breast cancer treatment
Kisunla ( Donanemab ): Treatment for Early Symptomatic Alzheimer's Disease (AD)- Evidence Review on Amyloid Targeting Therapy